Gyre Therapeutics Inc (GYRE)

Cost of Revenue

$6.81M

TTM · Period ending: · USD

GYRE logo

GYRE Cost of Revenue

Latest reported$6.81M
GYRE TTM Cost of Revenue ($480.93K → $6.81M)
High-resolution chart · PNG

GYRE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gyre Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,807,000
5,749,000
5,416,000
4,850,000
4,180,000
3,799,000
3,884,000
3,957,000
4,183,000
4,490,000
4,636,000
4,746,862
4,955,328
3,945,328
3,731,328
4,824,466
5,824,000
6,941,000
7,510,000
7,132,000
5,651,000
6,209,000
9,208,000
7,166,000
16,182,000
25,551,000
33,099,000
41,304,000
36,952,000
29,730,000
21,474,000
42,106,000
40,336,000
65,158,000
88,758,000
61,999,000
61,590,000
35,631,000
10,546,000
10,200,000
8,290,000
5,672,000
4,769,000
4,399,000
4,249,000
5,402,000
5,266,964
3,870,964
2,534,964
1,247,964
0
0
0
0
0
0
0
0
0
0
0
0
0
16,350,000
16,556,000
16,814,000
17,042,000
876,226
184,290,226
361,709,226
564,958,226
564,945,495
554,629,495
582,086,495
378,774,986
378,760,179
337,407,179
132,250,847
323,032,356
323,112,779
191,285,245
191,405,358
480,933
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.